---
title: "Adult Vaccination History and Plasma Biomarkers in Asymptomatic PREVENT-AD Participants"
id: "medrxiv-6-adult-vaccination-history-and-plasma-biomarker-signatures-in-the-asymptomatic"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-6-adult-vaccination-history-and-plasma-biomarker-signatures-in-the-asymptomatic"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.24.26361238v1?rss=1"
published_at: "2026-08-27T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Adult Vaccination History and Plasma Biomarkers in Asymptomatic PREVENT-AD Participants
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-6-adult-vaccination-history-and-plasma-biomarker-signatures-in-the-asymptomatic
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.24.26361238v1?rss=1)
- **Published At:** 2026-08-27T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This exploratory analysis used data from 192 cognitively unimpaired participants in the PREVENT-AD cohort to examine associations between **adult vaccination** history and Alzheimer disease (AD)-related and immune-related biomarker profiles. - Vaccination and infection histories were collected by structured questionnaire and compared with plasma and cerebrospinal fluid (CSF) biomarkers; adjusted regression models and false-discovery-rate (FDR) correction were applied. - Common adult vaccines—**influenza**, **herpes zoster**, **pneumococcal**, and **Td/Tdap**—showed no FDR-significant associations with the principal plasma **amyloid** and **tau** biomarker panel. - **Hepatitis B** vaccination was associated, within the AD biomarker panel, with lower plasma total tau/MAPT, p-tau181, and p-tau231 after correction; authors note these may reflect residual behavioral or healthcare-related confounding rather than causal effects. - Greater **vaccination-profile breadth** correlated with higher plasma **NPTX1** (beta = 0.261, p = 0.007, q = 0.049); a nominal association with lower Aβ42/40 ratio did not survive FDR correction. - Nominal associations for herpes zoster with lower CSF Aβ42 and pTau were attenuated after FDR correction and did not reach robust significance. - No robust FDR-significant associations emerged from analyses of viral-history interactions or psychological symptom measures. - Authors conclude that adult vaccination history was not linked to a broad plasma **amyloid** or **tau** signature in this asymptomatic, familial-risk cohort, but the NPTX1 and hepatitis B signals are hypothesis-generating. - The study is limited by cross-sectional design and potential confounding; authors call for longitudinal studies that include vaccine timing, infection burden, and repeated biomarker measurements to clarify whether vaccination influences AD-relevant biological pathways.
## Clinical Analysis & Structured Key Points
Adult Vaccination History and Plasma Biomarker Signatures in the Asymptomatic PREVENT-AD Cohort | medRxiv Skip to main content Adult Vaccination History and Plasma Biomarker Signatures in the Asymptomatic PREVENT-AD Cohort Sophie Charland , Melissa Savard , Isabel Sarty , Christine Dery , Sylvia Villeneuve , Cynthia Picard , View ORCID Profile Judes Poirier doi: https://doi.org/10.64898/2026.08.24.26361238 Sophie Charland 1 Centre for the Studies in the Prevention of Alzheimer Disease; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Melissa Savard 1 Centre for the Studies in the Prevention of Alzheimer Disease; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Isabel Sarty 1 Centre for the Studies in the Prevention of Alzheimer Disease; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Christine Dery 1 Centre for the Studies in the Prevention of Alzheimer Disease; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sylvia Villeneuve 2 Department of Psychiatry, McGill University Find this author on Google Scholar Find this author on PubMed Search for this author on this site Cynthia Picard 1 Centre for the Studies in the Prevention of Alzheimer Disease; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Judes Poirier 2 Department of Psychiatry, McGill University Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Judes Poirier For correspondence: judes.poirier{at}mcgill.ca Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background: Epidemiological studies increasingly associate several adult vaccinations with lower risk of Alzheimer disease (AD) and dementia, but the biological mechanisms underlying these observations remain unclear. We investigated whether adult vaccination history is associated with AD-related and immune-related biomarker profiles in cognitively unimpaired individuals at increased familial risk for AD. Methods: This exploratory study included 192 participants from the PREVENT-AD cohort. Adult vaccination and infection histories were collected using a structured questionnaire and examined in relation to plasma and cerebrospinal fluid (CSF) biomarkers. Adjusted regression models evaluated individual vaccine exposures, vaccination-profile breadth, broader proteomic signatures, CSF biomarkers, viral-history interactions, and psychological symptoms, with false-discovery-rate (FDR) correction applied for multiple testing. Results: Influenza, herpes zoster, pneumococcal, and Td/Tdap vaccination were not associated with FDR-significant differences in the principal plasma amyloid and tau biomarker panel. Hepatitis B vaccination was associated with lower plasma total tau/MAPT, p-tau181, and p-tau231 after correction within the AD biomarker panel, although these findings may reflect residual behavioral or healthcare-related confounding. Greater vaccination-profile breadth was associated with higher plasma NPTX1 (beta = 0.261, p = 0.007, q = 0.049), whereas its nominal association with a lower Amyloid Beta 42/40 ratio did not survive FDR correction. Nominal herpes zoster associations with lower CSF Amyloid Beta 42 and pTau were similarly attenuated after correction. No robust FDR-significant associations emerged from viral-history interaction or psychological symptom analyses. Conclusions: Adult vaccination history was not associated with a broad plasma amyloid or tau signature in this asymptomatic, familial-risk cohort. However, the association between broader vaccination exposure and higher NPTX1 suggests a potentially distinct synaptic-related signal, while the hepatitis B findings identify additional hypothesis-generating tau-related associations. Longitudinal studies incorporating vaccine timing, infection burden, and repeated biomarker measurements are needed to determine whether vaccination influences biological pathways relevant to AD resilience. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The PREVENT-AD study protocols, consent forms, and study procedures were approved by the McGill University Institutional Review Board and/or the Douglas Mental Health University Institute Research Ethics Board. All participants provided written informed consent. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data used in the present study are available upon reasonable request to the authors, subject to applicable ethical and privacy restrictions. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted August 27, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Adult Vaccination History and Plasma Biomarker Signatures in the Asymptomatic PREVENT-AD Cohort Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Adult Vaccination History and Plasma Biomarker Signatures in the Asymptomatic PREVENT-AD Cohort Sophie Charland , Melissa Savard , Isabel Sarty , Christine Dery , Sylvia Villeneuve , Cynthia Picard , Judes Poirier medRxiv 2026.08.24.26361238; doi: https://doi.org/10.64898/2026.08.24.26361238 Share This Article: Copy Citation Tools Adult Vaccination History and Plasma Biomarker Signatures in the Asymptomatic PREVENT-AD Cohort Sophie Charland , Melissa Savard , Isabel Sarty , Christine Dery , Sylvia Villeneuve , Cynthia Picard , Judes Poirier medRxiv 2026.08.24.26361238; doi: https://doi.org/10.64898/2026.08.24.26361238 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (612) Allergy and Immunology (892) Anesthesia (325) Cardiovascular Medicine (4753) Dentistry and Oral Medicine (473) Dermatology (406) Emergency Medicine (639) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1610) Epidemiology (15796) Forensic Medicine (32) Gastroenterology (1194) Genetic and Genomic Medicine (6964) Geriatric Medicine (726) Health Economics (1050) Health Informatics (4957) Health Policy (1422) Health Systems and Quality Improvement (1730) Hematology (578) HIV/AIDS (1328) Infectious Diseases (except HIV/AIDS) (16227) Intensive Care and Critical Care Medicine (1157) Medical Education (661) Medical Ethics (150) Nephrology (717) Neurology (7157) Nursing (360) Nutrition (1072) Obstetrics and Gynecology (1225) Occupational and Environmental Health (998) Oncology (3563) Ophthalmology (1032) Orthopedics (392) Otolaryngology (445) Pain Medicine (464) Palliative Medicine (139) Pathology (702) Pediatrics (1770) Pharmacology and Therapeutics (730) Primary Care Research (758) Psychiatry and Clinical Psychology (5810) Public and Global Health (9664) Radiology and Imaging (2371) Rehabilitation Medicine and Physical Therapy (1426) Respiratory Medicine (1236) Rheumatology (631) Sexual and Reproductive Health (762) Sports Medicine (571) Surgery (761) Toxicology (106) Transplantation (301) Urology (285)
## Related Clinical Research

- [MMR vaccines: separating measles, mumps, rubella shots — myths and facts](https://medichelpline.com/clinical-feed/medical-news-today-0-should-the-measles-mumps-rubella-vaccines-be-separate-myths-vs-facts.md)
- [FDA approves Moderna’s mRNA flu vaccine mFLUSIVA for adults 50+: what clinicians should know](https://medichelpline.com/clinical-feed/medical-news-today-0-moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-available.md)
- [Trust in Science: STAT launches dedicated reporting initiative](https://medichelpline.com/clinical-feed/stat-news-0-trust-in-science-a-new-stat-initiative.md)
- [Bundibugyo Ebola outbreak reveals gaps in Ebola preparedness and need for pan-filovirus tools](https://medichelpline.com/clinical-feed/stat-news-1-opinion-we-prepared-for-ebola-but-not-this-ebola.md)
- [Where Polygenic and Proteomic Risk Scores Diverge in Neurodegenerative Disease: Absorption and Co-](https://medichelpline.com/clinical-feed/medrxiv-10-absorption-and-co-expression-modules-show-where-polygenic-and-proteomic-risk.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.